Cargando…
Tumor-Preferential Induction of Immune Responses and Epidermal Cell Death in Actinic Keratoses by Ingenol Mebutate
The rapid and strong clinical efficacy of the first-in-class, ingenol mebutate, against actinic keratosis (AK) has resulted in its recent approval. We conducted the first comprehensive analysis of the cellular and molecular mode of action of topical ingenol mebutate 0.05% gel in both AK and uninvolv...
Autores principales: | Emmert, Steffen, Haenssle, Holger A., Zibert, John R., Schön, Margarete, Hald, Andreas, Hansen, Maria H., Litman, Thomas, Schön, Michael P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5017628/ https://www.ncbi.nlm.nih.gov/pubmed/27612149 http://dx.doi.org/10.1371/journal.pone.0160096 |
Ejemplares similares
-
The Role of Ingenol Mebutate in the Treatment of Actinic Keratoses
por: Ali, Faisal R., et al.
Publicado: (2012) -
Ingenol mebutate in the treatment of actinic keratoses: clearance
rate and adverse effects
por: Saraiva, Maria Isabel Ramos, et al.
Publicado: (2018) -
Efficacy of Ingenol Mebutate in the Treatment of Actinic Keratoses: A Pre- and Posttreatment Dermoscopic Comparative Analysis
por: Carbotti, Mattia, et al.
Publicado: (2018) -
Improved patient satisfaction using ingenol mebutate gel 0.015% for the treatment of facial actinic keratoses: a prospective pilot study
por: Emilio, Joanna, et al.
Publicado: (2016) -
Repeated Treatments with Ingenol Mebutate Prevents Progression of UV-Induced Photodamage in Hairless Mice
por: Erlendsson, Andrés Már, et al.
Publicado: (2016)